A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price increase of 82.22%. However, over the past six months, we’ve seen a weaker performance of 35.34%. The price of LPTX fallen by 132.16% over the last 30 days. And in the last five days, it has surged by 55.57%.
The stock price for Leap Therapeutics Inc. (LPTX) currently stands at $0.82. The stock experienced a substantial increase in the last session, hitting $0.84 after starting at $0.699. The stock’s lowest price was $0.67 before closing at $0.66.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Leap Therapeutics Inc. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.86 on 09/08/22 and the lowest value was $0.27 on 03/27/23.
52-week price history of LPTX Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Leap Therapeutics Inc.’s current trading price is -55.91% away from its 52-week high, while its distance from the 52-week low is 203.70%. The stock’s price range during this time has been between $0.27 and $1.86. The trading volume for the Healthcare sector company’s shares reached about 3.54 million for the day, which was higher than the average daily volume of 0.72 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Leap Therapeutics Inc. (LPTX) has experienced a quarterly rise of 36.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 96.38M and boasts a workforce of 44 employees.
Leap Therapeutics Inc.: Analysts’ Ratings Unveiled
As of right now, 2 analysts are rating Leap Therapeutics Inc. as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4865, with a change in price of +0.3999. Similarly, Leap Therapeutics Inc. recorded 822,632 in trading volume during the last 100 days, posting a change of +95.19%.
LPTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LPTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
LPTX Stock Stochastic Average
Today’s raw stochastic average for Leap Therapeutics Inc. over the last 50 days is 96.49%.This indicates a increase from the raw stochastic average of the past 20 days, which was 95.89%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 84.67% and 82.37%, respectively.